Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
DOI
PMC
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
Reversible and tissue-specific activation of MAP kinase signaling by tamoxifen in brafV637 ERT2 mice.
Genesis 51, 448-455 (2013)
Deregulated MAP kinase (MAPK) signaling plays key roles in developmental and adult disease processes, but the experimental activation of MAPK is a currently unresolved task. For the reversible induction of MAPK signaling, we generated transgenic mice harboring a tamoxifen inducible BRAF(V637E) ER(T2) fusion protein. The expression of the inducible BRAF kinase can be directed by Cre/loxP-mediated recombination to selected cell types and enables the highly specific activation of MAPK signalling in vivo. We show that MAPK signaling can be transiently activated in the brain, liver, or kidney of Braf(V637E) ER(T2) mice by a single injection of tamoxifen. Braf(V637E) ER(T2) mice provide a new versatile tool to study disease mechanisms elicited by MAPK activation, complementing gene knockout technology that is restricted to the analysis of loss-of-function phenotypes. genesis 1-8.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Mapk ; Braf ; Tamoxifen ; Estrogen Receptor ; Rosa26 ; Cre ; Loxp ; Transgenic Mice; B-raf ; Recombinase Activity ; Cre ; Proteins ; Erk ; Disorders ; Mechanism ; Apoptosis ; Pathway ; Models
ISSN (print) / ISBN
1526-954X
e-ISSN
1526-968X
Quellenangaben
Volume: 51,
Issue: 6,
Pages: 448-455
Publisher
Wiley
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Developmental Genetics (IDG)